CIK 0001438533
- Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 262383102
- Phone
- +1 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $79,495,607
- in 10 filings, $79.5M under 10b5-1 plans
Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dube Eric M −$38.5M CHIEF EXECUTIVE OFFICER sold 60% of stake
- Heerma Peter −$17.9M EVP, CHIEF COMMERCIAL OFFICER sold 71% of stake
- ROTE WILLIAM E. −$13.1M Chief Research Officer sold 68% of stake
- Cline Christopher R. −$3.2M CHIEF FINANCIAL OFFICER sold 37% of stake
- Inrig Jula −$2.8M EVP, Head of R&D & CMO sold 31% of stake
Reading 20 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-08 | Golding Cornelius E Director | Grant or award · Employee Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2015-06-08 | Meckler Jeffrey A Director | Grant or award | +2,000 | 37,000 | ||
| 2015-06-08 | Meckler Jeffrey A Director | Grant or award · Employee Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2015-04-01 | KOZARICH JOHN W Director | Grant or award | +20,000 | 20,000 | ||
| 2015-04-01 | KOZARICH JOHN W Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2015-03-31 | Coughlin Timothy P Director | Grant or award | +20,000 | 20,000 | ||
| 2015-03-31 | Coughlin Timothy P Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2014-12-12 | Plotkin Horacio Chief Medical Officer | Sale | −2,100 | $10.07 | $21K | 91,767 |
| 2014-11-25 | Meckler Jeffrey A Director | Purchase | +15,000 | $8.60 | $129K | 35,000 |
| 2014-11-21 | Shkreli Martin Fmr Officer Dir 10% Sharehldr | Sale | −252,847 | $8.41 | $2.1M | 1,765,168 |
| 2014-11-21 | Richardson Steven Gary Director | Purchase | +6,100 | $8.38 | $51K | 129,165 |
| 2014-11-21 | ASELAGE STEVE Chief Executive Officer | Purchase | +8,700 | $8.50 | $74K | 371,756 |
| 2014-11-20 | Shkreli Martin Fmr Officer Dir 10% Sharehldr | Sale | −134,354 | $8.23 | $1.1M | 2,018,015 |
| 2014-11-20 | ASELAGE STEVE Chief Executive Officer | Purchase | +1,300 | $8.20 | $11K | 363,056 |
| 2014-11-19 | Shkreli Martin Fmr Officer Dir 10% Sharehldr | Sale | −329,824 | $8.54 | $2.8M | 2,152,369 |
| 2014-11-19 | Golding Cornelius E Director | Purchase | +2,000 | $9.00 | $18K | 25,000 |
| 2014-11-18 | Shkreli Martin Fmr Officer Dir 10% Sharehldr | Sale | −254,975 | $9.19 | $2.3M | 2,482,193 |
| 2014-11-17 | Shkreli Martin Fmr Officer Dir 10% Sharehldr | Sale | −100,000 | $9.41 | $941K | 2,737,168 |
| 2014-11-17 | Plotkin Horacio Chief Medical Officer | Sale | −8,333 | $9.43 | $79K | 93,867 |
| 2014-11-17 | VALEUR JENSEN MARGARET E General Counsel | Grant or award | +100,000 | 100,000 |
Page 56 of 59 · 1,174 trades